Navigation Links
The Quigley Corporation Reports Third Quarter 2008 Results; Continues Investment in Pharmaceutical R&D Future
Date:10/30/2008

Continuing operations $0.07 $0.11 ($0.35) ($0.29)

Discontinued operations - (0.01) 0.07 (0.03)

Net income (loss) $0.07 $0.10 ($0.28) ($0.32)

Diluted weighted average

common shares

outstanding: 13,158,145 13,095,839 12,868,683 12,688,966

Consolidated Balance Sheets (Unaudited)

The following represents condensed financial data (in thousands) at September 30, 2008 and December 31, 2007:

2008 2007

($) ($)

Cash & cash equivalents 10,880 15,134

Accounts receivable, net 5,499 6,649

Inventory 5,074 4,136

Total current assets 22,632 28,835

Total assets 26,571 33,502

Total current liabilities 6,839 10,258

Total stockholders' equity 19,732 23,244


'/>"/>
SOURCE The Quigley Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. The Quigley Corporation Announces Sale of Its Health and Wellness Segment
2. The Quigley Corporation Reports Fourth Quarter & 2007 Annual Results; Increases Investment to $6.5 million in Pharmaceutical R&D in 2007
3. The Quigley Corporation Reports First Quarter 2008 Results - Increases Investment in Pharmaceutical R&D Future
4. The Quigley Corporation Names Gerard M. Gleeson to Succeed Retiring George J. Longo as Chief Financial Officer and Director
5. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
6. Brooke Franchise Corporation Announces Selected July Results
7. MedThink Communications Retained by NanoBio Corporation
8. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
9. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
10. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
11. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Innovative Applications of Flow Cytometry Win U.S. and European Researchers Free Accuri C6 Flow Cytometer(R) Systems 2Health News:Innovative Applications of Flow Cytometry Win U.S. and European Researchers Free Accuri C6 Flow Cytometer(R) Systems 3Health News:Innovative Applications of Flow Cytometry Win U.S. and European Researchers Free Accuri C6 Flow Cytometer(R) Systems 4Health News:InfoZoom Launches V6.4 of its Industry Leading In-Memory Data Analysis Software 2Health News:InfoZoom Launches V6.4 of its Industry Leading In-Memory Data Analysis Software 3Health News:Frost & Sullivan: E-Healthcare in Western Europe Presents a Significant Market Opportunity for Wireless Technologies 2Health News:Frost & Sullivan: E-Healthcare in Western Europe Presents a Significant Market Opportunity for Wireless Technologies 3Health News:REES Announces New Baltimore Office 2Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 2Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 3Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 4Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 5Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 6
Breaking Medicine Technology:Royalty Pharma Announces that Alexander von Perfall Joins Management Team 2Hill-Rom Announces Appointment of James R. Giertz to Board of Directors 2Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 2Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 37 Proven Steps 3A How to Defeat Stress Without Going Through the Embarrassment of Counseling 3A Proven Ways to Defeat Stress 49176 17 Proven Steps 3A How to Defeat Stress Without Going Through the Embarrassment of Counseling 3A Proven Ways to Defeat Stress 49176 27 Proven Steps 3A How to Defeat Stress Without Going Through the Embarrassment of Counseling 3A Proven Ways to Defeat Stress 49176 3iMedica Selected by NJ Physicians as Preferred EHR Vendor 49173 1iMedica Selected by NJ Physicians as Preferred EHR Vendor 49173 2Somanetics Reports Second Quarter Results and Extension of Exclusive Distribution Agreement With Covidien 49170 1Somanetics Reports Second Quarter Results and Extension of Exclusive Distribution Agreement With Covidien 49170 2Somanetics Reports Second Quarter Results and Extension of Exclusive Distribution Agreement With Covidien 49170 3Somanetics Reports Second Quarter Results and Extension of Exclusive Distribution Agreement With Covidien 49170 4Somanetics Reports Second Quarter Results and Extension of Exclusive Distribution Agreement With Covidien 49170 5Somanetics Reports Second Quarter Results and Extension of Exclusive Distribution Agreement With Covidien 49170 6Somanetics Reports Second Quarter Results and Extension of Exclusive Distribution Agreement With Covidien 49170 7Somanetics Reports Second Quarter Results and Extension of Exclusive Distribution Agreement With Covidien 49170 8Somanetics Reports Second Quarter Results and Extension of Exclusive Distribution Agreement With Covidien 49170 9Somanetics Reports Second Quarter Results and Extension of Exclusive Distribution Agreement With Covidien 49170 10